Company page
Sienna Biopharmaceuticals Inc
Sienna Biopharmaceuticals Inc, trading under the ticker SNNAQ, is a public company based in the United States with a market capitalization of approximately $30.91 million. The company focuses on developing innovative biopharmaceutical products. Sienna Biopharmaceuticals aims to address unmet medical needs in the healthcare sector.

- Ticker
- SNNAQ
- Market cap
- $31
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major